Evidence map›Paper›PMID 40046178›Full record

ArticleFrontiers in medicine2024

Preliminary study on the participation of TLR9 on erythrocyte surface combined with mtDNA in the monitoring of infectious diseases.

Ling Xiao, Haixia Xu, Siwei Liu, Zhanrui Cheng, Yujie Kong, Li Tian

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ling Xiao *Department of Blood Transfusion, Deyang People's Hospital, Deyang, China.
Haixia Xu *Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
Siwei LiuInstitute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
Zhanrui ChengInstitute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.
Yujie KongDepartment of Laboratory, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Li TianInstitute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: TLR9 is typically found within cells and plays a crucial role in identifying pathogenic and self-DNA in chronic inflammation and immune complexes. Recent discoveries indicate its presence on the surface of human red blood cells, where it engages in immune regulation by binding to free mtDNA. The purpose of this study is to explore the role of TLR9 as a pattern recognition receptor combined with mtDNA in the monitoring of infectious diseases. Methods: TLR9 presence on the surface of red blood cells was assessed using flow cytometry in both healthy individuals and patients with bacterial infections. Subsequently, DNA bound to the red blood cell surface was extracted separately from both groups. The absolute quantification of mtDNA copy numbers within the extracted DNA was conducted using qPCR technology, followed by statistical analysis. Additionally, the correlation between mtDNA copy numbers bound to red blood cell surfaces in bacterial infection patients with varying CRP concentrations was examined using univariate linear regression. Result: In healthy individuals, TLR9 expression on red blood cell surfaces averaged 8.81%. However, the average expression of TLR9 on red blood cell surfaces in patients with bacterial infection was 5.45%, which was lower than that in healthy people ( Conclusion: The elevation of erythrocyte-bound mtDNA during infection, coupled with its correlation with infection severity, suggests that monitoring the copy numbers of mtDNA bound to red blood cells via TLR9 could serve as a novel indicator for infection surveillance.

Indexed as

infectionmitochondrial DNAmonitor diseasered blood cellstoll-like receptor 9

Identifiers

PMID40046178
PMCPMC11879980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.